Terveystalo Oyj

HEL:TTALO.HE

7.12 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 340.1350.2342.4280.5322.4341.1334.8276.4318.2329.7327.5273.1275.3278.7279.7240.2209.2257.4270.3234258.6267.8197.9160.3189197.5189.9155.4183.6160.5146.464119.2140.65140.65
Cost of Revenue 274.2281.3371.2116.4134.9142.3140.8120.4131.7132.8135.9112.2120.7120.2122.9108.196.6119.9122.7107.3119.2123.793.57688.693.289.174.686.674.169.64356.2107.72107.72
Gross Profit 65.968.9-28.8164.1187.5198.8194156186.5196.9191.6160.9154.6158.5156.8132.1112.6137.5147.6126.7139.4144.1104.484.3100.4104.3100.880.89786.476.8216332.93132.931
Gross Profit Ratio 0.1940.197-0.0840.5850.5820.5830.5790.5640.5860.5970.5850.5890.5620.5690.5610.550.5380.5340.5460.5410.5390.5380.5280.5260.5310.5280.5310.520.5280.5380.5250.5290.2340.234
Reseach & Development Expenses 0012.20007.80002.600010000.60000.20000.30000000
General & Administrative Expenses 38.631.829.6000000022.520.9003.3000-2.4000-0.10001.80000.1000
Selling & Marketing Expenses 2.92.91.722.72.41.42.52.42.22.31.6004.60007.20007.10008.90007000
SG&A 41.534.731.322.72.41.42.52.42.224.822.521.23519.0667.93.74.744.84.243.7711.411.911.210.710.911.607.17.57.7037.703
Other Expenses 0000169.7177.2147.6178.3169.5163.5157.7139.7131.8126.2126109.2112124.4123.6110.7122.7119.188.26778.284.683.283.590.875.968.90958.800
Operating Expenses 41.534.731.3153.9172.4179.6149180.8171.9165.7157.7139.7131.8126.2126109.2112124.4123.6110.7122.7119.188.26778.284.683.283.590.875.968.90958.826.37726.377
Operating Income 24.434.2-60.110.21519.112.8-22.114.631.233.921.222.832.230.822.90.51323.816.116.724.916.117.322.12014-2.56.210.512.0974.46.5846.584
Operating Income Ratio 0.0720.098-0.1760.0360.0470.0560.038-0.080.0460.0950.1040.0780.0830.1160.110.0950.0020.0510.0880.0690.0650.0930.0810.1080.1170.1010.074-0.0160.0340.0650.0830.0370.0470.047
Total Other Income Expenses Net -6.9-4.6-6.3-6.6-5.2-5-3-2.2-0.50.1-2.4-2.5-2.4-2.3-2.9-2.9-2.4-2.4-3.9-3.4-3.8-3.6-2.2-0.2-2.7-2.3-9.6-4.8-5-4.9-5.011-4.7-5.222-5.222
Income Before Tax 17.529.6-66.43.69.814.19.8-24.314.131.331.818.720.429.927.920-1.910.619.912.712.921.313.917.119.417.74.4-7.31.25.67.086-0.31.3621.362
Income Before Tax Ratio 0.0510.085-0.1940.0130.030.0410.029-0.0880.0440.0950.0970.0680.0740.1070.10.083-0.0090.0410.0740.0540.050.080.070.1070.1030.090.023-0.0470.0070.0350.048-0.0030.010.01
Income Tax Expense 3.16-2.40.42.332.2-4.73664.24.265.53.9-0.41.83.82.32.54.13.81.14-13.6-1.7-0.4-1-0.2-0.537-1.10.8070.807
Net Income 14.323.6-64.13.37.511.17.6-19.611.125.325.814.516.223.922.416.1-1.58.816.110.510.317.210.11615.431.36.1-6.92.25.87.6060.82.1332.133
Net Income Ratio 0.0420.067-0.1870.0120.0230.0330.023-0.0710.0350.0770.0790.0530.0590.0860.080.067-0.0070.0340.060.0450.040.0640.0510.10.0810.1580.032-0.0440.0120.0360.0520.0070.0150.015
EPS 0.110.19-0.510.0260.0590.0880.06-0.150.090.20.20.110.130.190.180.13-0.010.070.130.080.080.140.080.130.120.210.052-0.060.020.050.0250.0070.0030.003
EPS Diluted 0.110.19-0.510.0260.0590.0880.06-0.150.0880.20.20.110.130.190.180.13-0.010.070.130.080.080.140.080.130.120.210.052-0.060.020.050.0250.0070.0030.003
EBITDA 49.359.851.537.14446.142.432.542.75858.546.244.253.153.845.323.135.946.838.738.847.126.829.332.530.214.87.616.719.119.4614.916.04316.043
EBITDA Ratio 0.1450.1710.150.1320.1360.1350.1270.1180.1340.1760.1790.1690.1610.1910.1920.1890.110.1390.1730.1650.150.1760.1350.1830.1720.1530.0780.0490.0910.1190.1330.1250.1140.114